Key result
Peripheral vascular disease was associated with a twofold increased risk of long-term mortality after coronary artery bypass graft surgery.
Why the study?
Does the presence of peripheral vascular disease increase long-term mortality in patients discharged alive after coronary artery bypass graft surgery?
Cohort (n=2,871)
Yes
Does the presence of peripheral vascular disease increase long-term mortality in patients discharged alive after coronary artery bypass graft surgery?
Peripheral vascular disease is a strong, independent predictor of long-term mortality in patients who have undergone successful coronary artery bypass graft surgery.
Answers are grounded in this paper and cite their sources.
PVD signals elevated long-term risk after CABG, warranting closer surveillance; leaves open whether targeted interventions improve survival.
OBJECTIVE: To examine the effect of peripheral vascular disease (PVD) on long-term mortality after successful myocardial revascularization. METHODS: We performed a regional cohort study of 2871 consecutive patients discharged alive after coronary artery bypass graft surgery at five tertiary care centers in Maine, New Hampshire, and Vermont between 1987 and 1989. Data reflecting patient characteristics, heart disease severity, and comorbidity were collected prospectively; the presence of clinical and subclinical indicators of PVD was determined by medical record review; and vital status was determined using the National Death Index (mean follow-up, 4.4 years). RESULTS: Five-year mortality following coronary artery bypass graft surgery was substantially higher in the 755 patients with indicators of PVD (20%; 95% confidence interval [CI], 17% to 23%) than in the 2116 patients without PVD (8%, 95% CI, 7 to 9; P<.001). The crude hazard ratio of long-term mortality associated with PVD was 2.77 (95% CI, 2.19 to 3.50; P<.001). After adjusting for their higher comorbidity scores, more advanced cardiac disease, and age, mortality rates in patients with PVD remained twice as high as those in patients without PVD (adjusted hazard ratio, 2.01; 95% CI, 1.57 to 2.58; P<.001). Long-term mortality was increased in patients with any of the indicators of PVD. Patients with multilevel PVD had especially high late mortality rates (adjusted hazard ratio, 2.46; 95% CI, 1.64 to 3.68; P<.001). CONCLUSIONS: Even after successful myocardial revascularization, patients with PVD remain at substantially increased risk for long-term mortality. The presence of clinical or subclinical PVD is important when predicting both short- and long-term outcomes in patients considering coronary artery bypass graft surgery.
No takes yet. Share an insight, caveat, or question.
John D. Birkmeyer (1996) conducted a cohort in coronary artery bypass graft surgery (n=2,871). Peripheral vascular disease vs. No peripheral vascular disease was evaluated on Five-year mortality (adjusted HR 2.01, 95% CI 1.57-2.58, p=<.001). Peripheral vascular disease was associated with a twofold increased risk of long-term mortality after coronary artery bypass graft surgery.
Synapse has enriched 10 related papers. Consider them for comparative context: